Kinetic analysis of 2-[11C]thymidine PET imaging studies of malignant brain tumors: Preliminary patient results

Molecular Imaging

Volumn 1, Issue 3, 2002, Pages 145-150

  Wells, Joanne M ^a   Mankoff, David A ^a,c   Eary, Janet F ^a   Spence, Alexander M ^a   Muzi, Mark ^a   O'Sullivan, Finbarr ^b   Vernon, Cheryl B ^a   Link, Jeanne M ^a   Krohn, Kenneth A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Brain tumors; Kinetic modeling; PET; Proliferation; 11C Thymidine

Indexed keywords

BLOOD; BRAIN; CELLS; DRUG THERAPY; MEDICAL IMAGING; METABOLISM; PATIENT TREATMENT;

CELLULAR PROLIFERATION;

ONCOLOGY;

CARBON; CARBON DIOXIDE; DIAGNOSTIC AGENT; DNA; THYMIDINE;

ARTICLE; BIOLOGICAL MODEL; BIOSYNTHESIS; BRAIN TUMOR; CELL DIVISION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HUMAN; KINETICS; METABOLISM; PATHOLOGY; SCINTISCANNING;

BRAIN NEOPLASMS; CARBON DIOXIDE; CARBON RADIOISOTOPES; CELL DIVISION; DNA, NEOPLASM; HUMANS; KINETICS; MODELS, NEUROLOGICAL; THYMIDINE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0013148568     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.1162/153535002760235445     Document Type: Article

References (19)

1. Curnes JT, Laster DW, Ball MR, Moody DM, Witcofski R (1986), MRI of radiation injury to the brain. Am J Roentgenol. 147:119-124.
2. Spence AM, Muzi M, Graham MM, O'Sullivan F, Krohn KA, Link JM, Lewellen TK, Lewellen B, Freeman SD, Berger MS, Ojemann GA (1998). Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]-glucose and FDG: Analysis of the FDG lumped constant. J Nucl Med. 39:440-448.
3. Muzi M, Freeman SD, Burrows RC, Wiseman RW, Link JM, Krohn KA, Graham MM, Spence AM (2001). Kinetic characterization of hexokinase isoenzymes from glioma cells: Implications for FDG imaging of human brain tumors. Nucl Med Biol. 28:107-116.
4. Mankoff DA, Dehdashti F, Shields AF (2000). Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors. Neoplasia. 2:71-88.
5. Krohn KA, Mankoff DA, Eary JF (2001). Imaging cellular proliferation as a measure of response to therapy. J Clin Pharmacol. 41:96S-103S.
6. Shields AF, Mankoff DA, Link JM, Graham MM, Eary JF, Kozawa SM, Zheng M, Lewellen B, Lewellen TK, Grierson JR, Krohn KA (1998). Carbon-11-thymidine and FDG to measure therapy response. J Nucl Med. 39:1757-1762.
7. Eary JF, Mankoff DA, Spence AM, Berger MS, Olshen A, Link JM, O'Sullivan F, Krohn KA (1999). 2-[C-11]thymidine imaging of malignant brain tumors. Cancer Res. 59:615-621.
8. Mankoff DA, Shields AF, Graham MM, Link JM, Muzi M, Eary JF, Krohn KA (1998). Kinetic analysis of 2-[C-11]-thymidine PET imaging studies: Compartmental model and mathematical analysis. J Nucl Med. 39:1043-1055.
9. 11C]-thymidine PET imaging studies: Validation studies. J Nucl Med. 40:614-624.
10. Cornford EM, Oldendorf WH (1975). Independent blood-brain barrier transport systems for nucleic acid precursors. Biochim Biophys Acta. 394:211-219.
11. 11C]-thymidine PET imaging studies of malignant brain tumors: Compartmental model investigation and mathematical analysis. Mol Imaging. 1:151-159.
12. 2 and Positron Emission Tomography. J Cereb Blood Flow Metab. 4:458-465.
13. 2 and Positron Emission Tomography. J Cereb Blood Flow Metab. 4:8-16.
14. Minoshima S, Koeppe RA, Kuhl DE, Arimizu N (1994). Integrated and automated data analysis for neuronal activation studies using positron emission tomography: Methodology and applications. Kaku Igaku. 31:891-908.
15. Vander Borght T, Labar D, Pauwels S, Lambotte L (1991). Production of 2-[C-11]-thymidine for quantification of cellular proliferation with PET. Appl Radiat Isot. 42:103-104.
16. Link JM, Grierson J, Krohn K (1995). Alternatives in the synthesis of 2-[C-11]-thymidine. J Labelled Compd Radiopharm. 37:610-612.
17. 18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med. 27:235-238.
18. Shields AF, Mankoff D, Graham MM, Zheng M, Kozawa SM, Link JM, Krohn KA (1996). Analysis of 2-[C-11]-thymidine blood metabolites in PET imaging. J Nucl Med. 37:290-296.
19. O'Sullivan F (1993). Imaging radiotracer model parameters in PET: A mixture analysis approach. IEEE Trans Med Imag. 12:399-412.